A

AEON

Aeon Biopharma

0.50

0.01+2.07%
After Hours: 0.5119  +0.0097  +1.93%19:58 05/13 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Revenue

0

0

0

0

0

Revenue

--

--

--

--

--

Other Revenue, Total

--

--

--

--

--

Cost of Revenue, Total

--

--

--

--

--

Gross Profit

--

--

--

--

--

Operating Expense

-72.98M

348.09M

48.43M

56.30M

3.59K

Selling/General/Admin.Expenses,Total

13.64M

19.79M

13.68M

11.15M

--

Research & Development

14.18M

33.05M

34.75M

25.73M

--

Depreciation/Amortization

--

--

--

--

--

Interest Exp.(Inc.), Net-Operating, Total

--

--

--

--

--

Unusual Expense (Income)

--

348.00M

0

19.42M

--

Other Operating Expenses, Total

-100.81M

-52.75M

--

--

3.59K

Operating Income

72.98M

-348.09M

-48.43M

-56.30M

-3.59K

Interest Inc.(Exp.),Net-Non-Op.,Total

-16.36M

-39.51M

-4.42M

795.00K

--

Gain(Loss) on Sale of Assets

--

--

--

--

--

Other, Net

-14.62M

2.97M

289.00K

-135.00K

--

Net Income Before Taxes

42.01M

-384.63M

-52.56M

-55.64M

-3.59K

Provision for Income Taxes

0

0

0

0

--

Net Income After Taxes

42.01M

-384.63M

-52.56M

-55.64M

-3.59K

Minority Interest

--

--

--

--

--

Equity in Affiliates

--

--

--

--

--

U.S. GAAP Adjustment

--

--

--

--

--

Net Income Before Extra. Items

42.01M

-384.63M

-52.56M

-55.64M

-3.59K

Total Extraordinary Items

--

--

--

--

--

Net Income

42.01M

-384.63M

-52.56M

-55.64M

-3.59K

Total Adjustments to Net Income

--

--

--

--

--

Income Available to Com Excl ExtraOrd

42.01M

-384.63M

-52.56M

-55.64M

-3.59K

Income Available to Com Incl ExtraOrd

42.01M

-384.63M

-52.56M

-55.64M

-3.59K

Dilution Adjustment

--

--

--

--

--

Diluted Net Income

42.01M

-384.63M

-52.56M

-55.64M

-3.59K

Diluted Weighted Average Shares

575.95K

516.15K

516.09K

516.09K

34.50M

Diluted EPS Excluding ExtraOrd Items

72.93231

-745.19878

-101.83487

-107.80476

-0.0001

Diluted EPS including ExtraOrd Items

72.931678

-745.194226

-101.834951

-107.80484

-0.000104

DPS – Common Stock Primary Issue

--

--

--

--

0

Diluted Normalized EPS

72.93231

-70.97205

-101.83487

-70.18344

-0.0001